www.virology-education.com

1ST CENTRAL AND EASTERN EUROPEAN MEETING ON

VIRAL HEPATITIS

WARSAW, POLAND • 22 - 23 JUNE 2015

AND CO-INFECTION WITH HIV

EVALUATION REPORT

2EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

EXECUTIVE SUMMARY

Over the last few years, the field of Viral Hepatitis and Co-infection has undergone several major changes. Therapeutic options are increasing and new data are becoming available incessantly which makes it challenging for healthcare professionals to stay informed and provide the best treatment possible for their patients. Also regional and local situations vary strongly and have a big impact on the decision making process of the clinician.

The Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV has been developed by regional and international Key Opinion Leaders for the medical and scientific community in Eastern and Central European countries. Advances in the treatment of viral Hepatitis and HIV are continuing at a rapid and exciting pace, presented and discussed at many large international conferences. Key challenges in the treatment of Hepatitis B and C as well as HIV are specific for this region and need to be discussed among clinicians and scientists from these countries. This meeting aims to provide a unique and much needed platform for scientific and medical interchange and education on treatment of Viral Hepatitis and Co-infection with HIV. Much time was allocated to discussions and Q&A sessions in order to stimulate interaction and dialogue.

The content of the meeting and the invited lectures were very well received. The presentation of Dr Jonathan Schapiro at the special session on the optimal use of integrase inhibitors received the highest score of the entire meeting, with an average of 4.9 (on a scale of 5).

98% of the respondents indicated they will recommend this workshop to their colleagues and 100% indicated they plan to attend this workshop again next year.

The first edition of the Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV had 125 participants from 24 countries. The largest group, as expected, was from Poland ( 39).The below chart illustrates their professional background.

Professional Background

Clinician75%

Researcher14%

Other11%

The Organizing Committee and the Organizing Secretariat are pleased with the evaluation results of the 1st edition of this meeting and are looking forward to an even more successful second edition in 2016!

3EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

CONTENT

Content

Executive Summary .............................................................................. 2

Content ................................................................................................. 3

Introduction ........................................................................................... 4

Background .............................................................................................4

Target audience ......................................................................................4

CME Accreditation ..................................................................................4

Meeting Objectives ..................................................................................4

Learning Objectives ................................................................................5

Meeting Partners .................................................................................. 6

Acknowledgements .............................................................................. 7

Organizing committee........................................................................... 8

Scientific Committee ............................................................................ 9

Participants’ Feedback ........................................................................10

Impact ...................................................................................................10

General Event Experience ....................................................................10

Program ...............................................................................................11

Invited Lectures ....................................................................................11

Abstract - driven presentations ............................................................13

Participants’ Feedback ........................................................................14

Organization ..........................................................................................14

Publicity ................................................................................................14

Meeting demographics ........................................................................15

Number of Participants ........................................................................15

Professional background ......................................................................15

Conclusion ...........................................................................................16

List of Participants ...............................................................................17

4EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

INTRODUCTION

This is the evaluation report of the 1st Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV, held on 22 - 23 June 2015 at the Hilton Warsaw Hotel in Warsaw, Poland. The Organizing Commitee and the Organizing Secretariat highly value the opinion of the participants in order to further improve the quality of the workshop. Participants were asked to complete an evaluation form to share their opinion on several subjects.

BACKGROUNDThe Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV was initiated in 2014 and has been developed by regional and international Key Opinion Leaders for the medical and scientific community in Eastern and Central European countries. Advances in the treatment of viral Hepatitis and HIV are continuing at a rapid and exciting pace, presented and discussed at many large international conferences. Key challenges in the treatment of Hepatitis B and C as well as HIV are specific for this region and need to be discussed among clinicians and scientists from these countries. This meeting aims to provide a unique and much needed platform for scientific and medical interchange and education on treatment of Viral Hepatitis and Co-infection with HIV.

The main objective of this meeting is to guide the Central/Eastern healthcare community regarding best practice for treating viral hepatitis and HIV co-infection and for stimulating collaborations to reach optimal patient care in this region.

FORMATThis 2-day international, abstract-driven scientific and educational meeting consisted of invited lectures, round-table discussions and oral abstract- and poster presentations. In order to ascertain an interactive workshop setting, much time was allocated to discussions.

TARGET AUDIENCEThe target audience of this workshop consists of healthcare professionals involved in daily care for HCV patients such as infectious disease doctors, gastro-enterologists, hepatologists and others.

CME ACCREDITATIONThe 1st Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV was designated for a maximum of 10 hours of European external CME credits.

MEETING OBJECTIVES• To educate the practicing clinician on the best treatment options for Viral Hepatitis & Co-infection with HIV;

• To share cutting-edge information and translate to daily clinical practice;

• To provide a Central/Eastern-European platform for interaction and dialogue;

• To stimulate discussion among different disciplines;

• To build collaborations and develop research activities.

5EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

LEARNING OBJECTIVESAfter participating in this activity, the participants will:

• Have an understanding of the basic concepts of Viral Hepatitis and Co-infection;

• Have an insight into the spread of Viral Hepatitis in Central/Eastern Europe;

• Be updated on the latest developments in treatment strategies for mono- and co-infected patients;

• Have an understanding of the treatment challenges in Central/Eastern Europe;

• Be able to identify and adjust treatment strategies in different patient populations;

• Have an overview of the advantages and possibilities of new antivirals in HCV therapy.

6EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

MEETING PARTNERS

Societatea Română de Boli Infecţioase şi HIV/SIDA

7EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

ACKNOWLEDGEMENTS

Financial support for the 1ST CENTRAL AND EASTERN EUROPEAN MEETING ON VIRAL HEPATITIS AND CO-INFECTION WITH HIV has been provided by the following companies:

GOLD LEVEL

PLATINUM LEVEL

EXHIBITOR

BRISTOL - MYERS SQUIBB

8EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

ORGANIZING COMMITTEE

CHARLES BOUCHER, MD, PHD Erasmus Medical Center Rotterdam, the Netherlands

SVITLANA ANTONYAK, MD Academy of Medical Sciences Kiev, Ukraine

PAVEL KHAYKIN, MD MainFachArzt Frankfurt, Germany

VADIM RASSOKHIN, PHD Center for the Prevention and Control of AIDS and Inf. Diseases St. Petersburg, Russia

ANDRZEJ HORBAN, MD, PHD Hospital for Infectious Diseases Warsaw, Poland

JONATHAN SCHAPIRO, MD Sheba Medical Centre, Tel Aviv, Israel

JÜRGEN ROCKSTROH, MD University of Bonn, Germany

ADRIAN STREINU CERCEL, MD, PHD Nat. Institute for ID “Prof. Dr. Matei Bals”, Bucharest, Romania

ALICJA WIERCINSKA – DRAPAŁO, MD, PHD Medical University of Warsaw Warsaw, Poland

CIHAN YURDAYDIN, MD University of Ankara Medical School Ankara, Turkey

9EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

SCIENTIFIC COMMITTEE

Krasimir Antonov, MD, PhD ”St.Ivan Rilski” University Hospital, Sofia, Bulgaria

Dénes Bánhegyi, MD National Institute for Health Promotion, Budapest, Hungary

Saulius Caplinskas, MD, PhD Centre for Communicable Diseases and AIDS, Vilnius, Lithuania

Peter Jarcuska, MD, PhD J. Šafárik University, Košice, Slovakia

Brygida Knysz, MD, PhD Medical University of Wroclaw, Wroclaw, Poland

Mojca Maticic, MD, PhD University Medical Centre, Ljubljana, Slovenia

Cristina Popescu, MD, PhD National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Romania

Dalibor Sedlácek, MD, PhD University Hospital of Pilzen, Pilzen, Czech Republic

Tengiz Tsertsvadze, MD, PhD AIDS and Clinical Immunology Research Center, Tbilisi, Georgia

10EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

PARTICIPANTS’ FEEDBACK

IMPACTAttending this meeting has changed/will change my:

(Strongly) agree Average (Strongly) disagree

Thinking 92% 8% 0%

Behavior 69% 28% 3%

Overall, this meeting has enhanced my professional effectiveness

95% 5% 0%

As a clinician, i will improve my daily practice as a result of attending this meeting

88% 6% 6%

GENERAL EVENT EXPERIENCEExcellent /very much

agree

Average/neutral Fair /disagree

Overall event experience 98% 2% 0%

Opportunity of networking 93% 5% 2%

Content of the conference 98% 2% 0%

Time allocation for discussion 93% 7% 0%

Time allocation per presentation 95% 5% 0%

No commercial bias (product selling) perceived 95% 5% 0%

I would recommend this meeting to my peers 98% 2% 0%

I plan to attend this meeting next year 100% 0% 0%

11EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

PROGRAM

INVITED LECTURES

MONDAY 22 JUNE

08.30 h Registration, welcome coffee

Session 1: HIV-HCV Coinfection: Situation in Central-Eastern Europe

Local Situation in Poland Milosz Parczewski, MD, PhD, Pomeranian Medical University in Szczecin, Poland

Excellent Good Average Fair Poor

Topic is interesting 65% 31% 4% 0% 0%

Content is relevant to my work 54% 25% 17% 4% 0%

Local Situation in Ukraine Larisa Moroz, MD, PhD, Vinnitsa National Medical University, Ukraine

Excellent Good Average Fair Poor

Topic is interesting 47% 41% 12% 0% 0%

Content is relevant to my work 35% 28% 28% 7% 2%

Local Situation in Romania Adrian Streinu Cercel, MD, PhD, Matei Bals Infectious Diseases Institute, Bucharest, Romania

Excellent Good Average Fair Poor

Topic is interesting 49% 35% 14% 2% 0%

Content is relevant to my work 39% 33% 24% 4% 0%

Local Situation in Baltic Countries Saulius Caplinskas, MD, PhD, Lithuanian Center for Communicable Diseases and AIDS, Lithuania

Excellent Good Average Fair Poor

Topic is interesting 57% 35% 8% 0% 0%

Content is relevant to my work 43% 27% 24% 6% 0%

Local Situation in Czech and Slovak Republics Viktor Aster, MD, PhD, Charles University, Prague, Czech Republic

Excellent Good Average Fair Poor

Topic is interesting 49% 39% 12% 0% 0%

Content is relevant to my work 31% 35% 30% 4% 0%

Local Situation in Turkey Cihan Yurdaydin, MD, University of Ancara Medical School, Turkey

Excellent Good Average Fair Poor

Topic is interesting 47% 35% 8% 10% 0%

Content is relevant to my work 33% 29% 27% 9% 2%

Session 2: Management of Hepatitis C

Natural History of HCV Infection Krzysztof Simon, MD, PhD, Medical University of Wroclaw, Poland

Excellent Good Average Fair Poor

Topic is interesting 58% 26% 6% 8% 2%

Content is relevant to my work 48% 22% 22% 6% 2%

12EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

PROGRAM

Management of End-stage Liver Disease Massimo Puoti, MD, Niguarda Cà Granda Hospital, Italy

Excellent Good Average Fair Poor

Topic is interesting 65% 28% 4% 3% 0%

Content is relevant to my work 56% 27% 10% 7% 0%

State of the Art Treatment of HCV Sanjay Bhagani, BSc FRCP, Royal Free Hospital, UK

Excellent Good Average Fair Poor

Topic is interesting 87% 13% 0% 0% 0%

Content is relevant to my work 79% 16% 5% 0% 0%

An Integrated Approach to HCV Treatment in People who Inject Drugs Cross Europe Mojca Maticic, MD, PhD, University Medical Centre, Ljubljana, Slovenia

Excellent Good Average Fair Poor

Topic is interesting 70% 30% 0% 0% 0%

Content is relevant to my work 66% 24% 10% 0% 0%

Management of Drug Drug Interactions David Back, PhD, University of Liverpool, United Kingdom

Excellent Good Average Fair Poor

Topic is interesting 87% 11% 2% 0% 0%

Content is relevant to my work 80% 9% 11% 0% 0%

TUESDAY 23 JUNE

Special session: Keys to Optimal Use of Integrase Inhibitors in Clinical Practice

Integrase Inhibitors: Virology and Resistance Charles Boucher, MD, PhD - Erasmus Medical Centre, Rotterdam, The Netherlands

Excellent Good Average Fair Poor

Topic is interesting 62% 36% 2% 0% 0%

Content is relevant to my work 59% 21% 15% 5% 0%

Speaker performance 67% 31% 2% 0% 0%

Clinically Relevant Drug Interactions Saye Khoo, MD, PhD, University of Liverpool, Liverpool, UK

Excellent Good Average Fair Poor

Topic is interesting 74% 26% 0% 0% 0%

Content is relevant to my work 74% 13% 8% 5% 0%

Speaker performance 82% 16% 2% 0% 0%

Translation to Clinical Management Jonathan Schapiro, MD, Sheba Medical Center, Tel Aviv, Israel

Excellent Good Average Fair Poor

Topic is interesting 86% 14% 0% 0% 0%

Content is relevant to my work 81% 7% 5% 7% 0%

Speaker performance 93% 5% 0% 2% 0%

13EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

PROGRAM

Session 3: Clinical Management of Hepatitis B Infection

Epidemiology of Hepatitis B in Central and Eastern Europe Adrian Streinu Cercel, MD, PhD, Matei Bals Infectious Diseases Institute, Bucharest, Romania

Excellent Good Average Fair Poor

Topic is interesting 60% 38% 2% 0% 0%

Content is relevant to my work 59% 21% 18% 2% 0%

State of the Art Treatment of Hepatitis B Maria Buti, MD, PhD, Hospital Vall d’Hebron, Spain

Excellent Good Average Fair Poor

Topic is interesting 65% 33% 2% 0% 0%

Content is relevant to my work 58% 33% 8% 3% 0%

Session 4: Clinical Management of Hepatitis C infection in Special Patient Populations

Acute Hepatitis C Infection Christoph Boesecke, MD, PhD, University of Bonn, Germany

Excellent Good Average Fair Poor

Topic is interesting 71% 19% 10% 0% 0%

Content is relevant to my work 60% 35% 5% 0% 0%

ABSTRACT - DRIVEN PRESENTATIONS

Average score

Excellent Good Average Fair Poor

Topic is interesting 45% 44% 8% 2% 0%

Content is relevant to my work 41% 37% 16% 4% 1%

14EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

PARTICIPANTS’ FEEDBACK

ORGANIZATIONExcellent/good Average Fair/poor

Content of electronic announcements 97% 3% 0%

Frequency of electronic announcements 97% 3% 0%

Information on coference website 97% 3% 0%

Online registration process 96% 4% 0%

Online abstract submission process 100% 0% 0%

Meeting venue 97% 3% 0%

Audiovisuals 97% 3% 0%

Onsite logistics 100% 0% 0%

Service level of Conference Secretariat 100% 0% 0%

PUBLICITYAttention was drawn to this meeting by: Influenced to attend this meeting by:

VE e-mail announcement

36%

VE Website26%

Internet search6%

Flyer at other

meetings3%

Via Partner organizations

16%

Colleague / word of mouth

13%

Meeting description

42%

Faculty27%

Scientific program

22%

Registration fee3%

Location3%

Other3%

15EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

MEETING DEMOGRAPHICS

NUMBER OF PARTICIPANTSThe first edition of the Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV had 125 participants from 24 countries. The largest group, as expected, was from Poland ( 39).

The geographical distribution of participants is as follows:

Albania 1

Belarus 2

Bosnia-Herzegovina 1

Belgium 2

Bulgaria 4

Croatia 2

Czech Republic 2

Estonia 1

Georgia 4

Germany 5

Israel 1

Italy 1

Latvia 2

Lithuania 4

Poland 39

Romania 12

Serbia 2

Slovenia 5

Spain 1

The Netherlands 1

Turkey 6

Ukraine 17

United Kingdom 9

USA 1

PROFESSIONAL BACKGROUNDMain activity Mainly employed by:

Clinician75%

Researcher14%

Other11%

University 36%

Hospital52%

Industry10%

Government1%

NGO1%

Area of expertise:

ID67%

Hepatology17%

Other16%

16EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

CONCLUSION

The overall opinion of the meeting was very positive, as can be deducted from the above scores. Participants were satisfied with the scientific content of the workshop as well as with the logistics and the format of the program. The Organizing Committee and the Organizing Secretariat are very pleased with the evaluation results of this workshop. The success and importance of this workshop have underlined the need for continuation. The second edition of the meeting will be held in Bucharest, Romania, in October 2016.

17EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

LIST OF PARTICIPANTS

Name, First name Institute Country

Ambrozaitis, Arvydas Vilnius University Lithuania

Andreychyn, Mykhaylo Ternopil Medical Institute Ukraine

Angeleski, Hristijan University Clinical Center Maribor Slovenia

Antonyak, Svitlana National Academy of Medical Sciences Ukraine

Arkliņš, Kaspars Gilead Sciences Latvia

Aster, Viktor Faculty Hospital Na Bulovce Czech Republic

Back, David University of Liverpool United Kingdom

Bander, Dorota Samodzielny Publiczny Wojewódzki Szpital Zespolony im. Marii Sklodowskiej – Curi

Poland

Barbulescu, Gabriel Bristol Myers Squibb Romania

Barska, Katarzyna Regional Specialist Hospital in Wroclaw, Research and Development Center

Poland

BASCIFTCI, HUSEYIN Gilead Sciences Turkey

Bhagani, Sanjay Royal Free Hospital United Kingdom

Bladowska, Joanna Wroclaw Medical University Poland

Boesecke, Christoph Universitätsklinikum Bonn Germany

Bondar, Borys AbbVie Biopharmaceuticals GmbH Ukraine

Boucher, Charles Erasmus Medical Center The Netherlands

Boucher, Charles Erasmus Medical Center The Netherlands

Bursa, Dominik Hospital for Infectious Diseases Poland

Buti, Maria Hospital Valle Hebron Spain

Caplinskas, Saulius Vilnius Infectious Diseases Hospital Lithuania

Carr, Val Gilead EMEA United Kingdom

Cielniak, Iwona Hospital for Infectious Diseases Poland

Cocuz, Elena Infections Hospital Brasov Romania

Cotirla, Mihaela Abbvie Romania

Czaja, Izabela Abbvie Poland

Czarnecki, Marcin Katedra i Klinika Chorób Zakaņnych Poland

Dakovic Rode, Oktavija University hospital for infectious diseases"Fran Mihaljevic" Zagreb

Croatia

Dembinski, Stan Axsan Poland

Dragneva, Sonya UH St. Ivan Rilski Bulgaria

Dressler, Stephan EATG - European AIDS Treatment Group Germany

Dyda, Tomasz Hospital for Infectious Diseases Poland

Fedorchenko, Sergii Institute of Epidemiology and Infectious Diseases "L.V.Gromashevskyi"

Ukraine

Ferrinho, Diogo Gilead Sciences Europe United Kingdom

Firlņg - Burkacka, Ewa PPL Poland

Fouche, Nicolas Gilead Sciences Europe United Kingdom

Gheorghita, Valeriu INBI Matei Bals Romania

Giedrojņ, Agata Abbvie Poland

Godlewska, Klaudia Wojewódzki Specjalistyczny Szpital im. Wł. Biegaņskiego w Łodzi

Poland

Gogia, Maka Georgian Harm Prevention Network Georgia

18EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

Gojak, Refet University Clinical Center Sarajevo Bosnia-Herzegovina

Gregorņiņ, Sergeja Clinical Center Ljubljana Slovenia

Griolet, Christophe Gilead Sciences Europe United Kingdom

Gronicz-Mleczko, Tamara Abbvie Poland

Hollanders, Els ViiV Healtcare Belgium

Horban, Andrzej Hospital for Infectious Diseases Poland

Iegorova, Tetiana Clinic No.5, Kiev Ukraine

Inci, Ayse ņstanbul Kartal Koņuyolu Yüksek ņhtisas Eņitim Ve Araņtırma Hastanesi

Turkey

Inglot, Małgorzata Katedra i Klinika Chorób Zakaņnych Poland

Iurko, Kateryna Kharkov national medical university Ukraine

Jaocha-Litwin, Justyna Wojewódzki Szpital Specjalistycznu im. J. Gromkowskiego

Poland

Jipa, Raluca INBI Matei Bals Romania

Kase, Kerstin West-Tallinn Central Hospital Estonia

Kerashvili, Vakhtang Center of infectious diseases and aids Georgia

Khaykin, Pavel MainFachArzt Germany

Khoo, Saye University of Liverpool United Kingdom

Knysz, Brygida Katedra i Klinika Chorób Zakaņnych Poland

Kocbach, Piotr PZOZ Poland

Koder, Marko Medicopharmacia d.o.o., Slovenia Slovenia

Kotecka , Kornelia Wojewódzki Specjalistyczny Szpital im. Wł. Biegaņskiego w Łodzi

Poland

Kozłowska, Joanna Hospital for Infectious Diseases Poland

Kurent , Anica General Hospital, Novo Mesto Slovenia

Kyrychenko, Tatyana UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY Ukraine

Latarska - Smuga, Dorota Abbvie Poland

Leszczyszyn-Pynka, Magdalena PUM Poland

Lipski, Kamil Gilead Sciences Poland Poland

Ludwiczak, Małgorzata Gilead Sciences Poland Poland

Łuksza - Biedula, Katarzyna Abbvie Poland

Lytvyn, Kateryna Dnipropetrovsk Medical Academy Ukraine

Matiņiņ, Mojca University of Ljubljana Medical Faculty Slovenia

Matkovskyi, Igor Vinnitsa AIDS Center Ukraine

Matulionytņ, Raimonda Vilnius University Lithuania

Mauss, Stefan Center for HIV & Hep.Gastroent. Germany

Mazur, Julita Gilead Sciences Poland

Mihailoviņ , Vesna Clinic for Infectious Diseases in Clinical center, Niš Serbia

Mikuła, Tomasz Hospital for Infectious Diseases Poland

Moroz, Larisa Vinnitsa National Medical Universty Ukraine

Nychyk, Natalia Ukraine

Parczewski, Miłosz Pomeranian Medical University Poland

Parris, Helen Gilead Sciences Europe United Kingdom

Pluta, Jan Medical University of Warsaw, Clinical Hospital Dzieciņtka Jezus

Poland

19EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland

Pluta, Magdalena Hospital for Infectious Diseases Poland

Pospieszynski, Jaroslaw Hospital for Infectious Diseases Poland

Potiy, Victoriia Donetsk National Medical University Ukraine

Pryshliak, Oleksandra Medical University Ivano - Frankovsk Ukraine

Puoti, Massimo Niguarda Ca'Granda Hospital Italy

Pyziak-Kowalska, Karolina Wojewódzki Szpital Zakaņny w Warszawie Poland

Ranin, Jovan Clinic for infectious and Tropical Diseases, Clinical center Serbia, Beograd

Serbia

Robaeys, Geert University of Hasselt Belgium

Rockstroh, Juergen University of Bonn Germany

Ross, Lisa ViiV Healthcare USA

Sargin, Fatma ņstanbul Göztepe Eņitim Ve Araņtırma Hastanesi Merdivenköy Polikliniņi

Turkey

Schapiro, Jonathan Sheba Medical Center Israel

Schonberger, Stanko Gilead Sciences Europe United Kingdom

Sedláņek, Dalibor Czech Republic

Siewaszewicz, Ewa Gilead Sciences Poland Poland

Simon, Krzysztof Wroclaw Medical University Poland

Siwak, Ewa PPL Poland

Smadu, Sebastian Victor Babes Hospital Romania

Smiechowicz, Gerard Gilead Sciences Poland Poland

Sobala-Szczygieł, Barbara Szpital nr I w Bytomiu, Oddzial Obserwacyjno-Zakaņny Poland

Soldatenko, Olga Belarus

Strashimirov, Dimitar Hospital of Infection Diseases Sofia Bulgaria

Streinu - Cercel, Anca Matei Bals Infectious Diseases Institute Romania

Streinu Cercel, Adrian Matei Bals Infectious Diseases Institute Romania

Tetradov, Simona Victor Babes Hospital Romania

Tiliscan, Catalin INBI Matei Bals Romania

Timchev, Andon Hospital of Infection Diseases Sofia Bulgaria

Ungurianu, Rodica INBI Matei Bals Romania

Valkov, Ivan UH St. Ivan Rilski Bulgaria

Voiniņ, Alina Vilnius Infectious Diseases Hospital Lithuania

WIERCIņSKA-DRAPAŁO, Alicja Hospital for Infectious Diseases Poland

Wnuk, Anita Samodzielny Publiczny Wojewódzki Szpital Zespolony im. Marii Sklodowskiej – Curi

Poland

Wójcik, Kamila WSS Poland

Yurdaydin, Cihan University of Ankara Medical School Turkey

Zabek, Piotr Hospital for Infectious Diseases Poland

Zakalashvili, Mamuka Clinic Mrcheveli Georgia

Zani, Zamir Regional Hospital "Omer Nishani", Gjirokaster Albania

Zekan, Sime University hospital for infectious diseases "Fran Mihaljevic", Zagreb

Croatia

Zubkiewicz-Zarņbska, Anna Klinka Chorób Zakaņnych, Chorób Watroby i Nabytych Niedoborów Odpornosciowyc

Poland

Zvirbulis, Viesturs Riga East Clinical Hospital, clinic "Infectology Centre of Latvia"

Latvia